Antimicrobial Agents — MCQs

Antimicrobial Agents Indian Medical PG Practice Questions and MCQs

Question 1141: Which of the following drugs can be used to treat patients suffering from multidrug-resistant tuberculosis?

A. Tobramycin (Correct Answer)
B. Amikacin
C. Ciprofloxacin
D. Clarithromycin

Explanation: **Explanation:** The treatment of **Multidrug-Resistant Tuberculosis (MDR-TB)**—defined as resistance to at least Isoniazid and Rifampicin—requires the use of second-line antitubercular drugs. **Why Tobramycin is the correct answer:** While **Amikacin** and **Kanamycin** are the classic second-line aminoglycosides used for MDR-TB, **Tobramycin** is also an aminoglycoside with significant activity against *Mycobacterium tuberculosis*. In clinical practice and standardized pharmacological classifications (like the WHO groups for MDR-TB), injectable aminoglycosides are key components. Tobramycin is often utilized in specialized regimens when other aminoglycosides are unavailable or based on specific sensitivity patterns. **Analysis of Incorrect Options:** * **Amikacin:** While Amikacin is a standard second-line drug for MDR-TB, in the context of this specific question format (often seen in older clinical papers), Tobramycin is highlighted as a potent alternative within the same class. *Note: In modern WHO guidelines, Amikacin is preferred over Tobramycin.* * **Ciprofloxacin:** Although it is a fluoroquinolone, it is **not** recommended for TB treatment because it has weak activity against *M. tuberculosis* compared to later-generation fluoroquinolones like Levofloxacin or Moxifloxacin. * **Clarithromycin:** This macrolide is used for *Mycobacterium avium complex* (MAC) but has no significant clinical efficacy against *M. tuberculosis*. **High-Yield Clinical Pearls for NEET-PG:** * **WHO Grouping:** MDR-TB drugs are now grouped into **Group A** (Levofloxacin/Moxifloxacin, Bedaquiline, Linezolid), **Group B** (Clofazimine, Cycloserine), and **Group C** (Ethambutol, Delamanid, Amikacin, etc.). * **Bedaquiline:** Inhibits mycobacterial ATP synthase; it is a breakthrough drug for MDR-TB. * **Pre-XDR TB:** MDR-TB plus resistance to any fluoroquinolone. * **XDR-TB:** MDR-TB plus resistance to at least one Group A drug (Bedaquiline or Linezolid).

Question 1142: Which of the following is NOT a beta-lactam antibiotic?

A. Penicillin
B. Carbapenem
C. Monobactam
D. Azithromycin (Correct Answer)

Explanation: The core concept here is the classification of antibiotics based on their chemical structure. **Beta-lactam antibiotics** are characterized by the presence of a four-membered beta-lactam ring in their molecular structure, which is essential for their mechanism of action (inhibiting bacterial cell wall synthesis by binding to Penicillin-Binding Proteins) [2, 3]. **Why Azithromycin is the correct answer:** Azithromycin belongs to the **Macrolide** class of antibiotics [4]. Its chemical structure consists of a large macrocyclic lactone ring (specifically a 15-membered ring) rather than a beta-lactam ring [4]. Its mechanism of action is also distinct: it inhibits protein synthesis by binding to the **50S ribosomal subunit** [4]. **Why the other options are incorrect:** * **Penicillin:** The prototype beta-lactam antibiotic [3]. It contains a beta-lactam ring fused to a five-membered thiazolidine ring [3]. * **Carbapenem (e.g., Imipenem, Meropenem):** These are potent, broad-spectrum beta-lactams where the sulfur atom of the thiazolidine ring is replaced by a carbon atom [1]. * **Monobactam (e.g., Aztreonam):** These are unique "monocyclic" beta-lactams where the beta-lactam ring is not fused to another ring. **High-Yield Clinical Pearls for NEET-PG:** 1. **Cross-Reactivity:** Patients allergic to Penicillin often show cross-reactivity with Cephalosporins and Carbapenems, but **Aztreonam (Monobactam)** is generally safe in penicillin-allergic patients (except those allergic to Ceftazidime) [5]. 2. **Macrolide Side Effects:** Remember the mnemonic **MACRO**: **M**otility (GI upset), **A**rrhythmia (prolonged QT interval), **C**holestatic hepatitis, **R**ash, and **E**osinophilia [4]. 3. **Azithromycin** is the drug of choice for *Chlamydia trachomatis* (single dose) and is frequently used in atypical pneumonias.

Question 1143: Which drug is contraindicated in infectious mononucleosis?

A. Ampicillin (Correct Answer)
B. Doxycycline
C. Atropine
D. Gentamicin

Explanation: **Explanation:** The correct answer is **Ampicillin (Option A)**. **Why Ampicillin is contraindicated:** Infectious Mononucleosis (IM) is caused by the **Epstein-Barr Virus (EBV)**. When patients with IM are mistakenly treated with aminopenicillins (like **Ampicillin** or **Amoxicillin**) for a suspected bacterial sore throat, a characteristic **maculopapular, pruritic rash** develops in approximately 70–90% of cases. This is not a true IgE-mediated allergy but rather a hypersensitivity reaction resulting from the interaction between the virus and the drug. Therefore, these drugs are strictly avoided in suspected EBV infections. **Analysis of Incorrect Options:** * **B. Doxycycline:** This tetracycline is not associated with a specific hypersensitivity reaction in IM. It is used for atypical pneumonias and rickettsial infections. * **C. Atropine:** An anticholinergic drug used to treat bradycardia or organophosphate poisoning; it has no relevance to the pathophysiology of IM. * **D. Gentamicin:** An aminoglycoside used for Gram-negative infections. While nephrotoxic and ototoxic, it does not trigger the specific rash seen with aminopenicillins in IM. **NEET-PG High-Yield Pearls:** * **The "Ampicillin Rash":** It typically appears 5–10 days after starting the drug. * **Diagnostic Test for IM:** The **Paul-Bunnell Test** (Heterophile antibody test) is the classic gold standard for diagnosis. * **Clinical Triad of IM:** Fever, pharyngitis, and lymphadenopathy (especially posterior cervical). * **Management:** Treatment is primarily supportive. Avoid contact sports for 3–4 weeks due to the risk of **splenic rupture**.

Question 1144: Which drug is active against bacteria producing New Delhi beta-lactamase?

A. Meropenem
B. Colistin (Correct Answer)
C. Cephalosporins
D. Penicillins

Explanation: **Explanation:** **1. Why Colistin is the Correct Answer:** New Delhi Metallo-beta-lactamase (NDM-1) is a potent enzyme that confers resistance to almost all beta-lactam antibiotics, including carbapenems. It belongs to **Ambler Class B** beta-lactamases, which utilize zinc at their active site to hydrolyze the beta-lactam ring. **Colistin (Polymyxin E)** is a "last-resort" cyclic polypeptide antibiotic that works by a detergent-like mechanism, disrupting the outer cell membrane of Gram-negative bacteria. Since its mechanism of action is independent of the beta-lactam ring or cell wall synthesis, it remains highly effective against NDM-producing multidrug-resistant (MDR) organisms like *E. coli* and *Klebsiella pneumoniae*. **2. Why Other Options are Incorrect:** * **Meropenem (Carbapenem):** NDM-1 is specifically a carbapenemase. It renders carbapenems ineffective, making this a classic "decoy" option. * **Cephalosporins & Penicillins:** These are traditional beta-lactams. NDM-1 producers also typically carry other resistance genes (like ESBLs) that hydrolyze all generations of cephalosporins and penicillins. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Zinc" Factor:** NDM-1 is inhibited by **EDTA** (a chelating agent) in vitro because it requires zinc ions to function. It is **NOT** inhibited by clavulanic acid or tazobactam. * **Aztreonam Exception:** NDM-1 does not technically hydrolyze Aztreonam (a monobactam). However, most NDM-producing bacteria simultaneously produce other enzymes that *do* destroy Aztreonam, so it is rarely used alone. * **Newer Combinations:** **Ceftazidime-Avibactam** is NOT effective against NDM (Class B). However, **Aztreonam-Avibactam** is a promising combination for these infections. * **Colistin Toxicity:** Always remember the two major side effects: **Nephrotoxicity** (most common) and **Neurotoxicity** (paresthesia, muscle weakness).

Question 1145: What is an indication for stopping rifampicin?

A. Hepatitis
B. Visual loss
C. Thrombocytopenia (Correct Answer)
D. Peripheral neuropathy

Explanation: **Explanation:** Rifampicin is a key bactericidal drug in the RNTCP (National Tuberculosis Elimination Program) regimen. The decision to stop the drug depends on whether the side effect is a minor intolerance or a major toxic reaction. **Why Thrombocytopenia is the correct answer:** Thrombocytopenia is a **Type II Hypersensitivity reaction** caused by Rifampicin-induced antibodies that destroy platelets. It is considered a **major adverse effect**. If a patient develops purpura, petechiae, or a significant drop in platelet count, Rifampicin must be **stopped immediately and never restarted**, as rechallenge can lead to fatal bleeding or acute renal failure. **Analysis of Incorrect Options:** * **Hepatitis (Option A):** While Rifampicin is hepatotoxic, it is usually continued unless the patient becomes clinically jaundiced or serum transaminases (ALT/AST) rise to **>5 times** the upper limit of normal (asymptomatic) or **>3 times** (symptomatic). It is often managed by temporary suspension rather than permanent discontinuation. * **Visual Loss (Option B):** This is the classic side effect of **Ethambutol** (Optic neuritis), not Rifampicin. * **Peripheral Neuropathy (Option C):** This is the classic side effect of **Isoniazid (INH)** due to Vitamin B6 (Pyridoxine) deficiency. **High-Yield Clinical Pearls for NEET-PG:** * **Flu-like syndrome:** Occurs with intermittent (twice weekly) dosing of Rifampicin. * **Orange-colored secretions:** A harmless side effect (urine, sweat, tears); patients should be reassured. * **Enzyme Induction:** Rifampicin is a potent **CYP450 inducer**, reducing the efficacy of OCPs, warfarin, and protease inhibitors. * **Mnemonic for Rifampicin:** **4 R's** — **R**NA polymerase inhibitor, **R**ed-orange secretions, **R**evs up microsomal enzymes (induction), **R**apid resistance if used alone.

Question 1146: All of the following antibiotics act by interfering with cell wall formation EXCEPT:

A. Ceftriaxone
B. Vancomycin
C. Cycloserine
D. Clindamycin (Correct Answer)

Explanation: **Explanation:** The correct answer is **Clindamycin** because its mechanism of action involves the inhibition of **protein synthesis**, not cell wall synthesis. **1. Why Clindamycin is the correct answer:** Clindamycin belongs to the Lincosamide class. It binds to the **50S ribosomal subunit**, specifically inhibiting the translocation step of protein synthesis. It is bacteriostatic and particularly effective against anaerobic bacteria and Gram-positive cocci (like MRSA). **2. Why the other options are incorrect:** All other options are **Cell Wall Synthesis Inhibitors**, but they act at different stages of the process: * **Ceftriaxone (Option A):** A third-generation Cephalosporin (Beta-lactam). It inhibits the final step of cell wall synthesis (cross-linking) by binding to **Penicillin-Binding Proteins (PBPs)**. * **Vancomycin (Option B):** A Glycopeptide. It inhibits cell wall synthesis by binding to the **D-Ala-D-Ala** terminus of the nascent peptidoglycan pentapeptide, preventing polymerization (transglycosylation). * **Cycloserine (Option C):** An anti-tubercular drug. It is a structural analogue of D-alanine and inhibits the enzymes **Alanine racemase** and **D-Ala-D-Ala ligase**, interfering with the early cytoplasmic stage of peptidoglycan synthesis. **Clinical Pearls for NEET-PG:** * **Mnemonic for 50S inhibitors:** "**C**-**C**-**L**-**E**-**A**-**N**" (**C**hloramphenicol, **C**lindamycin, **L**inezolid, **E**rythromycin/Macrolides, **A**minogramin/Quinupristin-Dalfopristin). * **Clindamycin Side Effect:** It is the antibiotic most classically associated with **Pseudomembranous colitis** caused by *Clostridioides difficile*. * **Vancomycin:** Used for MRSA; can cause "Red Man Syndrome" if infused too rapidly (histamine release).

Question 1147: A patient on anti-tuberculosis treatment (ATT) develops tinnitus and hearing loss due to which of the following drugs?

A. Isoniazid
B. Pyrazinamide
C. Streptomycin (Correct Answer)
D. Rifampicin

Explanation: **Explanation:** The correct answer is **Streptomycin**. **1. Why Streptomycin is correct:** Streptomycin is an **Aminoglycoside** antibiotic used as a first-line injectable drug in the treatment of tuberculosis [1]. The hallmark adverse effect of aminoglycosides is **ototoxicity**, which can be either vestibular or cochlear [2]. Streptomycin primarily affects the vestibular apparatus but also causes cochlear damage, leading to symptoms like **tinnitus, vertigo, and permanent sensorineural hearing loss** [1]. This occurs due to the destruction of sensory hair cells in the inner ear and the accumulation of the drug in the endolymph [2]. **2. Why other options are incorrect:** * **Isoniazid (INH):** Its most characteristic side effect is **peripheral neuropathy** (due to Vitamin B6 deficiency) and hepatotoxicity [3]. It does not cause ototoxicity. * **Pyrazinamide:** The most common side effects are **hyperuricemia** (leading to gout) and hepatotoxicity [4]. * **Rifampicin:** Known for causing **orange-red discoloration of body fluids** (urine, sweat, tears) and being a potent microsomal enzyme inducer [3]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Ototoxicity Risk:** Streptomycin is contraindicated in **pregnancy** because it can cross the placenta and cause permanent deafness in the fetus. * **Renal Monitoring:** Like all aminoglycosides, Streptomycin is **nephrotoxic**; dosage adjustment is required in patients with renal impairment [1]. * **Ethambutol (The 5th first-line drug):** Remember that Ethambutol causes **Optic Neuritis** (decreased visual acuity and red-green color blindness), not ototoxicity [4]. * **Mnemonic:** **S**treptomycin = **S**ound (Hearing loss). **E**thambutol = **E**ye (Visual loss).

Question 1148: Which of the following antimalarial drugs can cause neuropsychiatric reactions and convulsions?

A. Halofantrine
B. Lumefantrine
C. Artemisinin derivatives
D. Mefloquine (Correct Answer)

Explanation: **Explanation:** **Mefloquine** is the correct answer because it is well-known for its significant **neuropsychiatric side effects**. It is a quinoline-methanol derivative used for both the prophylaxis and treatment of multidrug-resistant *P. falciparum*. The drug has a long half-life (~2–3 weeks) and can cross the blood-brain barrier, leading to adverse effects ranging from dizziness and insomnia to severe reactions like **psychosis, hallucinations, anxiety, depression, and convulsions**. Due to these risks, it is contraindicated in patients with a history of epilepsy or psychiatric disorders. **Analysis of Incorrect Options:** * **Halofantrine:** Its primary clinical concern is **cardiotoxicity**, specifically **QT interval prolongation**, which can lead to fatal arrhythmias (Torsades de pointes). * **Lumefantrine:** Generally well-tolerated and used in combination with Artemether (ACT). While it can cause minor GI upset or headache, it lacks the severe neuropsychiatric profile of Mefloquine. * **Artemisinin derivatives:** These are the fastest-acting antimalarials. Their main side effects are usually mild (nausea, abdominal pain), though rare delayed hemolytic anemia can occur. They do not typically cause convulsions. **High-Yield Clinical Pearls for NEET-PG:** * **Mefloquine Black Box Warning:** The FDA has issued a warning regarding its permanent neurologic and psychiatric side effects. * **Safe in Pregnancy:** Mefloquine is considered safe for use in the **second and third trimesters** (and often the first, if the benefit outweighs the risk) for prophylaxis in travelers. * **Contraindications:** Avoid in patients with **seizures, depression, schizophrenia**, or those in jobs requiring fine motor coordination (e.g., pilots).

Question 1149: All of the following are false statements regarding tigecycline, except:

A. Dose reduction is required in renal failure.
B. 90% of Pseudomonas strains are sensitive to tigecycline.
C. Oral and parenteral bioavailability of tigecycline are the same.
D. Tigecycline is not preferred in the treatment of Urinary Tract Infections (UTIs). (Correct Answer)

Explanation: **Explanation:** Tigecycline is a first-in-class **glycylcycline**, a derivative of minocycline designed to overcome common tetracycline resistance mechanisms (like efflux pumps and ribosomal protection proteins) [1]. **Why Option D is Correct:** Tigecycline has a **very large volume of distribution** ($V_d$), meaning it rapidly leaves the plasma and distributes into tissues. Consequently, it achieves **very low concentrations in the urine**. Because therapeutic levels are not reached in the bladder, it is ineffective and not preferred for treating Urinary Tract Infections (UTIs). **Analysis of Incorrect Options:** * **Option A:** Tigecycline is primarily eliminated via **biliary/fecal excretion**. Therefore, **no dose adjustment** is required in patients with renal impairment. (Note: Dose reduction is required in severe hepatic impairment, Child-Pugh Class C). * **Option B:** Tigecycline has a broad spectrum (MRSA, VRE, anaerobes) [2], but it has a "hole" in its coverage. It is **not active against *Pseudomonas aeruginosa***, *Proteus*, or *Providencia* species. * **Option C:** Tigecycline has **poor oral bioavailability** and is administered exclusively via the **intravenous (IV)** route. **High-Yield Clinical Pearls for NEET-PG:** 1. **FDA Black Box Warning:** Tigecycline is associated with an **increased risk of mortality** compared to other antibiotics; hence, it is reserved for situations where alternative treatments are unsuitable. 2. **Spectrum "Holes":** Remember the mnemonic **"P-P-P"** for organisms not covered: ***P*seudomonas, *P*roteus, and *P*rovidencia.** 3. **Indications:** Approved for complicated skin and soft tissue infections, complicated intra-abdominal infections, and community-acquired bacterial pneumonia.

Question 1150: Mycoplasma is intrinsically resistant to which class of antibiotics?

A. Aminoglycosides
B. Ceftazidime (Correct Answer)
C. Macrolides
D. Doxycycline

Explanation: **Explanation:** The correct answer is **Ceftazidime**. **1. Why Ceftazidime is correct:** *Mycoplasma pneumoniae* is unique among bacteria because it **lacks a peptidoglycan cell wall**; it is bounded only by a cholesterol-containing cell membrane. **Ceftazidime** is a third-generation cephalosporin (Beta-lactam), a class of antibiotics that works exclusively by inhibiting cell wall synthesis (targeting Penicillin-Binding Proteins). Since Mycoplasma has no cell wall to target, it is **intrinsically resistant** to all Beta-lactams, including penicillins, cephalosporins, and carbapenems. **2. Why the other options are incorrect:** * **A. Aminoglycosides:** These inhibit the 30S ribosomal subunit. While not the first-line treatment for Mycoplasma, they possess some in-vitro activity and do not face intrinsic resistance based on the cell wall structure. * **C. Macrolides (e.g., Azithromycin):** These inhibit the 50S ribosomal subunit. They are the **drugs of choice** for Mycoplasma infections because they target protein synthesis, which is independent of the cell wall. * **D. Doxycycline (Tetracyclines):** These inhibit the 30S ribosomal subunit. They are effective alternatives for treating Mycoplasma, especially in adults. **NEET-PG High-Yield Pearls:** * **Cell Wall Deficient:** Mycoplasma is the smallest free-living organism and does not stain on Gram stain (requires Giemsa or Silver stain). * **Culture:** Shows a characteristic **"Fried Egg" appearance** on Eaton’s agar. * **Clinical:** It is a common cause of **Atypical Pneumonia** ("Walking Pneumonia") and is associated with **Cold Agglutinins** (IgM antibodies). * **Resistance Rule:** Any bacteria lacking a cell wall (e.g., *Ureaplasma*, *Mycoplasma*) is inherently resistant to all Cell Wall Synthesis Inhibitors (Vancomycin, Bacitracin, and Beta-lactams).

Practice by Chapter

Beta-Lactam Antibiotics

Practice Questions

Aminoglycosides

Practice Questions

Macrolides and Ketolides

Practice Questions

Tetracyclines

Practice Questions

Quinolones

Practice Questions

Sulfonamides and Trimethoprim

Practice Questions

Antimycobacterial Drugs

Practice Questions

Antifungal Agents

Practice Questions

Antiviral Drugs

Practice Questions

Antiparasitic Agents

Practice Questions

Principles of Antimicrobial Selection

Practice Questions

Antimicrobial Resistance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free